Skip to main content
. 2022 Dec 28;12(1):223. doi: 10.3390/jcm12010223

Figure 2.

Figure 2

64CuCl2 PET/CT in prostate cancer relapse. (A) 64CuCl2 biodistribution with high activity in the liver, and kidneys and lesser in the bowel. 64CuCl2 PET/CT image of pelvis from a old man treated with radical prostatectomy with rising PSA level demonstrated copper-avid recurrence in vescicourethral anastomosis (B) and nodes (C). Adapted from ref. [21] with (This research was originally published in JNM. A. Piccardo et al. 64CuCl2 PET/CT in prostate cancer relapse. J. Nucl. Med. 2018, 59, 444–451. ©SNMMI).